Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Eidos TherapeuticsEnanta PharmaceuticalsMadrigal PharmaceuticalsSupernus PharmaceuticalsInsmed
SymbolNASDAQ:EIDXNASDAQ:ENTANASDAQ:MDGLNASDAQ:SUPNNASDAQ:INSM
Price Information
Current Price$39.58$71.91$95.96$27.97$19.35
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$37.5714$115.6667$177.00$54.7143$38.2857
% Upside from Price Target-5.07% downside60.85% upside84.45% upside95.62% upside97.86% upside
Trade Information
Market Cap$1.46 billion$1.40 billion$1.49 billion$1.47 billion$1.75 billion
Beta-0.990.971.191.622.98
Average Volume152,657215,015203,695550,7371,070,301
Sales & Book Value
Annual RevenueN/A$206.63 millionN/A$408.90 million$9.84 million
Price / SalesN/A6.85N/A3.59175.42
CashflowN/A$3.8475 per shareN/A$2.3683 per shareN/A
Price / CashN/A18.69N/A11.81N/A
Book Value$4.22 per share$20.32 per share$30.99 per share$8.67 per share$2.70 per share
Price / BookN/A3.54N/A3.237.17
Profitability
Net Income$-33,290,000.00$71.95 million$-32,810,000.00$110.99 million$-324,280,000.00
EPS($1.86)$3.48($2.22)$2.05($4.17)
Trailing P/E RatioN/A20.66N/A13.64N/A
Forward P/E RatioN/AN/AN/A14.42N/A
P/E GrowthN/AN/AN/A$1.01N/A
Net MarginsN/A29.22%N/A25.66%N/A
Return on Equity (ROE)-30.80%15.16%-11.62%22.36%-126.95%
Return on Assets (ROA)-29.42%14.33%-11.38%10.52%-47.66%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%N/AN/A0.70%1.01%
Current Ratio20.89%22.01%38.06%2.72%7.54%
Quick Ratio20.89%22.01%38.06%2.53%7.31%
Ownership Information
Institutional Ownership Percentage32.46%88.57%61.77%99.34%N/A
Insider Ownership Percentage70.10%11.35%47.69%6.57%4.95%
Miscellaneous
Employees2811317448373
Shares Outstanding36.88 million19.68 million15.43 million52.45 million89.21 million
Next Earnings Date11/5/2019 (Estimated)11/25/2019 (Estimated)11/5/2019 (Estimated)11/5/2019 (Estimated)10/29/2019 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable
 Eidos TherapeuticsEnanta PharmaceuticalsMadrigal PharmaceuticalsSupernus PharmaceuticalsInsmed

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel